44 related articles for article (PubMed ID: 38598571)
1. Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy.
Weber WP; Hanson SE; Wong DE; Heidinger M; Montagna G; Cafferty FH; Kirby AM; Coles CE
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438776. PubMed ID: 38815195
[TBL] [Abstract][Full Text] [Related]
2. The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
van Roozendaal LM; de Wilt JH; van Dalen T; van der Hage JA; Strobbe LJ; Boersma LJ; Linn SC; Lobbes MB; Poortmans PM; Tjan-Heijnen VC; Van de Vijver KK; de Vries J; Westenberg AH; Kessels AG; Smidt ML
BMC Cancer; 2015 Sep; 15():610. PubMed ID: 26335105
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Upfront Surgical Management of the Axilla in Patients with Breast Cancer.
Williams AD; Weiss A
Clin Breast Cancer; 2024 Jun; 24(4):271-277. PubMed ID: 38220539
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis.
Ram R; Singh J; McCaig E
Int J Breast Cancer; 2014; 2014():513780. PubMed ID: 25383226
[TBL] [Abstract][Full Text] [Related]
5. Location-Based Oncological Outcomes of Sentinel Node Dissection in Radical Prostatectomy.
Droghetti M; Ozman O; Berrens AC; Piazza P; Paccapelo A; van Vliet R; Schiavina R; Brunocilla E; Bekers E; Donswijk M; van Leeuwen FWB; van der Poel H
J Urol; 2024 May; ():101097JU0000000000004051. PubMed ID: 38787799
[TBL] [Abstract][Full Text] [Related]
6. Uncertainties and controversies in axillary management of patients with breast cancer.
Weber WP; Davide Gentilini O; Morrow M; Montagna G; de Boniface J; Fitzal F; Wyld L; Rubio IT; Matrai Z; King TA; Saccilotto R; Galimberti V; Maggi N; Andreozzi M; Sacchini V; Castrezana López L; Loesch J; Schwab FD; Eller R; Heidinger M; Haug M; Kurzeder C; Di Micco R; Banys-Paluchowski M; Ditsch N; Harder Y; Paulinelli RR; Urban C; Benson J; Bjelic-Radisic V; Potter S; Knauer M; Thill M; Vrancken Peeters MJ; Kuemmel S; Heil J; Gulluoglu BM; Tausch C; Ganz-Blaettler U; Shaw J; Dubsky P; Poortmans P; Kaidar-Person O; Kühn T; Gnant M
Cancer Treat Rev; 2023 Jun; 117():102556. PubMed ID: 37126938
[TBL] [Abstract][Full Text] [Related]
7. Management of Axilla in 2015 in Indian Scenario.
Vijaykumar DK; Arunlal M
Indian J Surg Oncol; 2015 Dec; 6(4):435-9. PubMed ID: 27065670
[TBL] [Abstract][Full Text] [Related]
8. Management of the Positive Axilla in 2017.
Ozmen T; Huff Vinyard A; Avisar E
Cureus; 2017 May; 9(5):e1216. PubMed ID: 28589065
[TBL] [Abstract][Full Text] [Related]
9. Research gaps in sentinel lymph node biopsy in breast cancer.
Hamdy O
Oncologist; 2024 Jun; ():. PubMed ID: 38837063
[No Abstract] [Full Text] [Related]
10. Axillary Surgery for Breast Cancer in 2024.
Heidinger M; Weber WP
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730576
[TBL] [Abstract][Full Text] [Related]
11. ALND can be safely omitted for patients with sentinel-node macrometastases.
Killock D
Nat Rev Clin Oncol; 2024 Jun; 21(6):402. PubMed ID: 38637648
[No Abstract] [Full Text] [Related]
12. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
13. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C; Canavese G; Gatzemeier W; Barbieri E; Bottini A; Sagona A; Caraceni G; Testori A; Di Maria Grimaldi S; Dani C; Boni L; Bruzzi P; Fernandes B; Scorsetti M; Zambelli A; Gentile D;
Br J Surg; 2023 Aug; 110(9):1143-1152. PubMed ID: 37471574
[TBL] [Abstract][Full Text] [Related]
15. De-escalation of axillary surgery in patients outside Z0011 criteria.
Giannakou A; Gooch J; Gergelis KR; Weiss A
Surgery; 2023 Aug; 174(2):416-418. PubMed ID: 37156648
[TBL] [Abstract][Full Text] [Related]
16. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
17. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
de Boniface J; Filtenborg Tvedskov T; Rydén L; Szulkin R; Reimer T; Kühn T; Kontos M; Gentilini OD; Olofsson Bagge R; Sund M; Lundstedt D; Appelgren M; Ahlgren J; Norenstedt S; Celebioglu F; Sackey H; Scheel Andersen I; Hoyer U; Nyman PF; Vikhe Patil E; Wieslander E; Dahl Nissen H; Alkner S; Andersson Y; Offersen BV; Bergkvist L; Frisell J; Christiansen P; ;
N Engl J Med; 2024 Apr; 390(13):1163-1175. PubMed ID: 38598571
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
